Daunorubicin and respiratory distress Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4627083-8
Daunorubicin side effect was reported by a Physician from on Mar 17, 2005. Male patient, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: confusional state, coordination abnormal, febrile neutropenia, hypotension, respiratory distress, urinary incontinence . Daunorubicin dosage: 45 MG/M2 OTHER. Patient was hospitalized. Patient died on 02/23/2005.

Daunorubicin Side Effects Report #4638524-4
Daunorubicin side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: arteriosclerosis, electrocardiogram st-t change, ischaemic cardiomyopathy, pyrexia, respiratory distress, sepsis , sinus tachycardia. Daunorubicin dosage: 45 MG/M2/DAY, IV, DAYS 1-3. During the same period patient was treated with CYTARABINE, ZOSUQUIDAR. Patient recovered.

Daunorubicin Side Effects Report #4663136-6
Daunorubicin side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: confusional state, coordination abnormal, disease progression, febrile neutropenia, hypotension, infusion related reaction, respiratory distress, urinary incontinence . Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient died on 02/23/2005.

Daunorubicin Side Effects Report #4677183-1
Daunorubicin side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, child 9 years of age, was diagnosed with agranulocytosis and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemodialysis, multi-organ failure, pulmonary oedema, respiratory distress. Daunorubicin dosage: 60 MG, IV. During the same period patient was treated with CYTARABINE, METHOTREXATE, VANCOMYCIN HYDROCHLORIDE, TOBRAMYCIN, TEICOPLANIN, CEFTRIAXONE, TRETINOIN, ALLOPURINOL. Patient died.


Daunorubicin Side Effects Report #4686019-4
Daunorubicin side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, child 9 years of age, was diagnosed with agranulocytosis and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemodialysis, multi-organ failure, pulmonary oedema, respiratory distress. Daunorubicin dosage: 60 MG IV. During the same period patient was treated with CYTARABINE, METHOTREXATE, VANCOMYCIN HYDROCHLORIDE, TOBRAMYCIN, TEICOPLANIN, CEFTRIAXZONE, TRETINOIN, ALLOPURINOL. Patient died.

Daunorubicin Side Effects Report #5909930-2
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2008. Female patient, weighting 9.99 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, hepatomegaly, hepatotoxicity, respiratory distress. Daunorubicin dosage: 14 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, CIPROFLOXACIN, DAPSONE, FILGRASTIM. Patient was hospitalized. Patient recovered.